TLRYNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends May 31

Tilray Brands, Inc.

Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026

$3.03−0.01 (-0.33%)

Close on Oct 19, 2026

Market cap: $404.02M
P/E (TTM): –
Dividend yield: –

Tilray Brands, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-05-31	FY 2025 2025-05-31	FY 2024 2024-05-31	FY 2023 2023-05-31	FY 2022 2022-05-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31
Revenue	915	821	789	627	628	167	43	21	13
Cost of Revenue	655	581	566	480	512	190	29	9.16	9.97
Gross Profit	260	241	223	147	117	-23	14	11	2.67
Research & Development	0.36	0.28	0.64	0.68	1.52	9.17	5.86	3.17	1.14
Selling, General & Admin	–	–	–	–	–	175	64	15	8.49
Selling & Marketing	–	–	–	–	–	64	16	7.16	3.60
General & Administrative	204	167	167	165	163	111	49	7.50	4.89
Advertising Expenses	42	37	42	31	31	3.56	0.62	–	–
Operating Expenses	323	2,523	398	1,517	727	–	–	–	–
Operating Income	-63	-2,283	-175	-1,370	-610	-304	-58	-7.50	-7.05
Interest Expense	30	41	49	47	40	–	5.67	0.69	0.77
Interest & Investment Income	6.25	11	13	33	12	0.15	–	–	–
Income from Equity Investments	–	–	–	-7.97	5.21	-4.50	–	–	–
Other Non-Operating Income	-1.37	10	-38	-67	198	2.50	2.01	0.01	0.00
Merger & Restructuring Charges	13	34	16	9.25	0.80	–	–	–	–
Asset Impairment Charges	0	2,096	0	934	378	112	–	–	–
Gain (Loss) on Investments	-4.53	-5.55	-4.86	-2.19	-4.91	2.63	-0.01	–	–
Gain (Loss) on Sale of Assets	0.51	1.79	4.20	0.05	0.68	-2.44	0.00	-0.01	0.00
Legal Settlements	-3.90	-17	-8.25	0.51	-17	–	–	–	–
Pretax Income	-88	-2,302	-249	-1,450	-441	-330	-72	-7.81	-7.88
Income Tax Expense	17	-121	-27	-7.18	-6.54	-8.45	-4.45	–	–
Net Income incl. Noncontrolling Interests	-105	-2,181	-222	-1,443	-434	–	–	–	–
Minority Interest in Earnings	16	5.38	23	9.66	43	–	–	–	–
Net Income	-121	-2,187	-245	-1,453	-477	-321	-68	-7.81	-7.88
EPS (Basic)(per share)	-1.09	-24.56	-3.30	-23.50	-9.90	-32.00	-8.20	-1.00	-1.10
EPS (Diluted)(per share)	-1.09	-24.56	-3.30	-23.50	-9.90	-32.00	-8.20	-1.00	-1.10
Shares Outstanding (Basic, Weighted)(shares)	112	89	74	62	48	10	8.30	7.50	7.50
Shares Outstanding (Diluted, Weighted)(shares)	112	89	74	62	48	10	8.30	7.50	7.50
EBITDA	–	–	–	–	-456	-288	-54	-5.65	-5.10

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Aug 31, 2026

Profitability, TTM

Gross margin: 29.1%
Operating margin: -9.3%
Net margin: -17.1%
Return on equity, FY2026: -7.8%

Financial strength

Current ratio: 1.88
Debt to equity: 0.08
Debt to assets: 5.4%
Cash to current liabilities: 49.9%

Valuation

P/E ratio: –
Price to sales: 0.42
Price to book: 0.25
Dividend yield: –